Shandong will be Chinese medicine formula particles into health insurance! The scope of application is extended to primary medical institutions.

On October 21st, Shandong Provincial Health Insurance Bureau issued a notice on the payment of Chinese medicine formula granules (trial) and public consultation (hereinafter referred to as the "Draft for Comments"), and decided to include the chinese medicine formula products produced by six departments, such as the Ministry of Industry and Information Technology of Shandong Province, which have been approved for payment by the provincial drug regulatory bureau for the record and the payment of Chinese medicine tablets approved by the state-mandated medical insurance fund.
scope of application to medical institutions above the first level (including the first level).
is also worth noting that during this year's outbreak of neo-crown pneumonia, Chinese medicine formula particles have been widely recognized.
since Hubei will meet the requirements of Chinese medicine formula particles into the medical insurance payment, Shandong Province, the pharmaceutical province will also land this policy, for the chinese medicine formula particles market to open up the imagination space.
The use of Chinese medicine tablets shall not exceed 30% of the draft for comments, it is pointed out that Chinese medicine formula particles in accordance with the medical insurance catalogue "Class B drugs" management, the relevant medical insurance payment provisions in accordance with the national drug catalogue corresponding to the provisions of Chinese medicine tablets, all places may not adjust themselves.
"□" are not paid for by the Health Insurance Fund when used alone, and the Prescription Health Insurance Fund, which consists entirely of these Chinese medicine formula particles, is not paid.
proportion of individuals who use Chinese medicine formula particles is determined by the co-ordination areas according to the affordability of the medical insurance fund.
the individual pays first, the remaining drug expenses shall be carried out in accordance with the basic medical insurance policy of the integrated district.
, the draft stressed that Chinese medicine formula particles as a supplement to Chinese medicine tablets, its prescription follows the prescription regulations of Chinese medicine tablets.
to strengthen the application of Chinese medicine formula particles and price management, to prevent inflated prices, increase the burden on the masses.
trial period, Shandong Province approved the research pilot enterprise production into the medical insurance payment of Chinese medicine formula particles applicable to the scope of application to the first level (including the first level) or more medical institutions.
the use of Chinese medicine formula particles in the same medical institution shall not exceed 30% of Chinese medicine tablets.
to strengthen the quality management of Chinese medicine formula particles and clinical use of assessment and evaluation, to ensure the use of effectiveness, reasonable diagnosis and treatment, reasonable use of drugs.
addition, the medical insurance departments of the co-ordination areas should incorporate the use of Chinese medicine formula particles in the scope of agreement management and assessment of fixed-point medical institutions, improve the assessment and evaluation indicators, and increase supervision and inspection efforts.
the medical insurance information supervision platform to strengthen the monitoring of the use of Chinese medicine formula particles, accurately grasp the use of drugs, to prevent unreasonable use of drugs, to avoid unreasonable expenditure of the fund.
the hedging fraud behavior, such as serial exchange projects, to recover the medical insurance fund, in accordance with the law seriously deal with.
the inclusion of qualified Chinese medicine formula particles in medical insurance is not long ago, Shandong Province Medical Security Bureau jointly issued four departments of "on strengthening medical security to support the development of Chinese medicine" landing.
is worth noting that since this year, more and more regions have issued the Implementation Opinions on Promoting the Innovation and Development of Traditional Chinese Medicine, and Chinese medicine products will receive more policy support.
health insurance policies in various parts of this year's new crown pneumonia epidemic prevention and control, Chinese medicine formula particles are widely used, has been recognized by doctors, patients.
as a key policy, Medicare payments are being turned on to Chinese medicine formula particles.
In the first half of this year, the four departments of Hubei Province jointly issued the Notice on the Inclusion of Chinese Medicine Formula Particles Produced by Pilot Enterprises in the Province into the Scope of Basic Medical Payments, and from July 1, chinese Medicine Formula Particles produced by pilot enterprises in the province have been granted access to provincial medical insurance, and are used in designated medical institutions above the second level of the province for a trial period of two years.
as early as 2009, Beijing included Chinese medicine formula particles in the "Beijing Basic Medical Insurance and Industrial Injury Insurance Drug Catalog" reimbursement scope.
is also worth noting that at present, the policy of paying for Chinese medicine formula grain health insurance is different.
Beijing, Zhejiang, Yunnan and other provinces and cities directly clear Chinese medicine formula particles into health insurance, there are some areas, such as Shenzhen, Chinese medicine formula particles into the management of Chinese medicine tablets, according to the provisions of the realization of medical insurance accounting.
, there are also some provinces, such as Hebei, Hubei, Shandong is the province's enterprises produced Chinese medicine formula particles into health insurance.
, however, some provinces and cities, such as Fujian, Heilongjiang and Shantou, have chosen not to reimburse Chinese medicine formula particles.
2017, Fujian Province announced the first batch of supplementary health insurance directory, it will be excluded from the basic health insurance fund payment range.
, Japan, South Korea and other places have been Chinese medicine formula particles into health insurance.
look at the domestic, in the industry's view, the health care policy will have a huge impact on the Chinese medicine formula particles market, only under the health insurance increase to achieve sales volume.
chinese medicine market has experienced negative growth this year as a result of a series of policy adjustments.
environment, because the Chinese medicine formula particle market is still in rapid cultivation, good policy continues.
, according to the State Health Insurance Administration proposed biological products and Traditional Chinese medicine centralized procurement symposium uploaded the news, Chinese medicine formula particles are not included in the collection.
at present, dozens of enterprises nationwide have obtained the pilot production qualification of Chinese medicine formula particles.
encouraged by the health care policy, the future market for Chinese medicine formula particles is full of imagination space.
.